Skip to Main Content
Back to News

New Analyst Forecast: $CNTA Given 'Buy' Rating

None

We just received data on a new analyst forecast for $CNTA. Guggenheim gave a rating of 'Buy' for $CNTA.

$CNTA Analyst Ratings

Wall Street analysts have issued reports on $CNTA in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Guggenheim issued a "Buy" rating on 10/06/2025
  • Chardan Capital issued a "Buy" rating on 08/12/2025
  • Needham issued a "Buy" rating on 05/28/2025

To track analyst ratings and price targets for $CNTA, check out Quiver Quantitative's $CNTA forecast page.

$CNTA Price Targets

Multiple analysts have issued price targets for $CNTA recently. We have seen 5 analysts offer price targets for $CNTA in the last 6 months, with a median target of $30.0.

Here are some recent targets:

  • Debjit Chattopadhyay from Guggenheim set a target price of $28.0 on 10/06/2025
  • Benjamin Burnett from Wells Fargo set a target price of $31.0 on 09/03/2025
  • Rudy Li from Chardan Capital set a target price of $30.0 on 08/12/2025
  • Danielle Brill from Truist Securities set a target price of $30.0 on 07/21/2025
  • Ami Fadia from Needham set a target price of $35.0 on 05/28/2025

$CNTA Insider Trading Activity

CNTA Insider Trades

$CNTA insiders have traded $CNTA stock on the open market 28 times in the past 6 months. Of those trades, 2 have been purchases and 26 have been sales.

Here’s a breakdown of recent trading of $CNTA stock by insiders over the last 6 months:

  • ARJUN GOYAL has made 2 purchases buying 462,585 shares for an estimated $5,865,242 and 0 sales.
  • SAURABH SAHA (Chief Executive Officer) has made 0 purchases and 5 sales selling 220,000 shares for an estimated $2,951,112.
  • TIA L BUSH (Chief Technology & Quality Ofc) has made 0 purchases and 3 sales selling 84,792 shares for an estimated $1,885,840.
  • IQBAL J HUSSAIN (General Counsel) has made 0 purchases and 9 sales selling 76,000 shares for an estimated $1,416,379.
  • MARIO ALBERTO ACCARDI (President, Orexin Program) has made 0 purchases and 5 sales selling 38,494 shares for an estimated $651,596.
  • GREGORY M WEINHOFF (Chief Business Officer) has made 0 purchases and 4 sales selling 41,742 shares for an estimated $582,321.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CNTA Hedge Fund Activity

We have seen 62 institutional investors add shares of $CNTA stock to their portfolio, and 64 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles